JPRN-jRCT2052210004
Completed
Phase 3
A validation study of the cognitive assessment program - AiBS-01-001
Kitajima Manabu0 sites75 target enrollmentApril 9, 2021
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Kitajima Manabu
- Enrollment
- 75
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The inclusion criteria on this study is as follows;
- •1\. Participants who sign the consent document by their own decision. The consent can be obtained by proxies when the participants with dementia have substiantial impairments in their abilities to understand.
- •If those with dementia seem to be able to comprehend the information provided, the consent needs to be obtained from both the participant and his/her proxy.
- •2\. Participants without current or past diagnosis of neurological or mental diseases.
Exclusion Criteria
- •The exclusion criteria on this study is as follows;
- •1\. Participants with ophthalmic diseases such as strabismus, cataract, glaucoma and diabetic retionopathy. These diseases have a possibility to affect the gaze detection and tracking system because of weakened eyesight and partial visual field defect. Participants are asked to take off their glasses prior to the eye\-tracking calibration, if they're wearing the following types of glasses to correct visual acuity.
- •1\) dark shades sunglasses which make it impossible for the eye\-tracking system to capture a clear view of the eyes
- •2\) glasses with small frame or thick frame
- •3\) glasses with high lens power for myopia of \-6\.25 diopters or more
- •4\) glasses of \+13 diopters or more for people who had surgical removal of the crystalline lens
- •5\) multifocal lens glasses whose lower section consists of convex lens of short focal length
- •2\. Participants who can't complete MMSE because they have neurological diseases with movement disorders or difficulties in hearing
- •3\. Participants who took the eye\-tracking based cognitive assessment used in this study or MMSE within the past three months prior to the enrollment date
- •4\. Participants who are considered not to be eligible for this study by the study responsible physician. For example, participants with eye movement or alignment abnormalities because of nystagmus or trauma. Also, participants who can't maintain sitting posture during cognitibe assessments are excluded.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Investigation for the evaluation of the cognitive functional decline by the anticancer drug in Japanese.healthy personJPRN-UMIN000026290Showa university15
Completed
Not Applicable
Prospective Assessment of Cognitive Function in Coronary AngiographyMild Cognitive Dysfunction in patients with Ischaemic Heart DiseaseCardiovascular - Other cardiovascular diseasesMental Health - Studies of normal psychology, cognitive function and behaviourACTRN12605000772640St. vincent's Hospital Foundation50
Not yet recruiting
Not Applicable
Effectiveness of Cognitive Enhancement Package on self-esteem.CTRI/2020/06/026014Ashmita
Completed
Not Applicable
A verification study of the influence for cognitive and physical functions by using the sanitary products four consecutive weeksJPRN-UMIN000032743niversity of Tsukuba School of Integrative200
Completed
Not Applicable
The evaluation of the cognitive function in patients with fracture and the effect of rehabilitation on cerebral functioFemoral fracture, Spinal compression fractureJPRN-UMIN000016406Department of Biological Regulation, School of Health Science, Faculty of Medicine, Tottori University50